Clinical Trial Update: Early Tranexamic Acid and Modulating the Inflammatory Response in Sepsis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial led by Assiut University is testing early tranexamic acid to modulate the inflammatory response in sepsis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Assiut University | Conditions: Sepsis | Phase 3 | Status: RECRUITING